Država: Malta
Jezik: engleski
Izvor: Malta Medicines Authority
furosemide 10 mg/ml
Alapis S.A.
C03CA01
furosemide
oral solution
Authorised
2011-05-18
PACKAGE LEAFLET: INFORMATION FOR THE USER FUROSEMIDE ALAPIS 10MG/ML ORAL SOLUTION FUROSEMIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have further questions, ask your doctor or your pharmacist. • This medicine has been prescribed only for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours • If any of these side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET 1 What Furosemide Alapis is and what it is used for 2 Before you take Furosemide Alapis 3 How to take Furosemide Alapis 4 Possible side effects 5 How to store Furosemide Alapis 6 Further information 1. WHAT FUROSEMIDE ALAPIS IS AND WHAT IT IS USED FOR The name of your medicine is Furosemide Alapis 10mg/ml Oral Solution (referred to as Furosemide Alapis in this leaflet). The active ingredient in your medicine is furosemide. Furosemide belongs to a group of medicines called diuretics, or water tablets. Furosemide can be used to remove the levels of excess water in the body caused by heart, lung, kidney, liver or blood vessel problems. 2. BEFORE YOU TAKE FUROSEMIDE ALAPIS DO NOT TAKE FUROSEMIDE ALAPIS AND TELL YOUR DOCTOR IF YOU: • are allergic (hypersensitive) to furosemide, sulphonamides or any other ingredients in this liquid (listed in Section 6). The signs of an allergic reaction include a rash, itching or shortness of breath • hav Pročitajte cijeli dokument
Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Furosemide Alapis 10 mg / ml Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml of solution contains 10 mg of Furosemide. Each 1 ml of solution also contains 98.5 mg Ethanol and 350 mg Sorbitol For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oral Solution Clear solution with a characteristic orange odor. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Furosemide is indicated in all conditions requiring prompt diuresis in patients who are unable to take solid dose forms. Indications include cardiac, pulmonary, hepatic and renal oedema, peripheral oedema due to mechanical obstruction or venous insufficiency and hypertension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION This liquid should only be taken orally. The medication should be administered in the morning to avoid nocturnal diuresis. _Adults (more than 18 years of age)_: The usual initial daily dose is 40mg. This may be adjusted until an effective dose is achieved. _ _ _Elderly_: in the elderly, Furosemide is generally eliminated more slowly. Dosage should be titrated until the required response is achieved. This product is not recommended to use in children below 18 years of age. 4.3 CONTRAINDICATIONS Hypovolaemia or dehydration. Anuria. Renal failure with anuria not responding to furosemide, or as a result of poisoning by nephrotoxic or hepatotoxic agents, or associated with hepatic coma. Severe hyperokalaemia, hyperkalaemia and severe hyponatraemia. Pre- comatose and comatose states asso Pročitajte cijeli dokument